ITM and CNL’s Joint Venture Actineer

Gowling WLG advised ITM on the Joint Venture. ITM Isotope Technologies Munich SE (“ITM”), a leading radiopharmaceutical biotech company, and Canadian Nuclear Laboratories (“CNL”), the manager...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here